Have you read Dr Sarah Heynemann's paper which serves as a reminder we need to continuously re-examine the ethics of clinical research, particularly in relation to trial access, participant selection, communication and consent, and role delineation. linkedin.com/company/961418… #OzOnc

Thank you 🙏🏽 #OXTOX #RCT participant #59 from #ConcordCancerCentre - wonderful to have you on board to help find out if #ibudilast prevents #CIPN from #oxaliplatin in #CRCSM @GICancer @drprunellab @MartinStockler @janette_vardy #SuppOnc #SurvOnc #OzOnc

& today we welcome another participant (#58) from Mid-North Coast Cancer Centre to #OXTOX #RCT - thanks 🙏🏽to them & #clinicaltrials team! Racing towards our 100 participant target #SuppOnc #PsyOnc #OzOnc #CRCSM @GICancer @janette_vardy @COSAoncology

Wonderful to share Dr Priscilla Gates's reporting cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy link.springer.com/article/10.100… #CRCI #PsyOnc #SuppOnc #OzOnc #lymphoma @PocoG @COSA_Surviv @meikrishnasamy

Feeling grateful to 2 new participants on #OXTOX #RCT & to teams @ Sydney Aventist & Royal North Shore Hospitals. Now 57/100 people on study assessing whether ibudilast reduces #CIPN during #oxaliplatin #chemo for #CRCSM #SuppOnc #OzOnc @GICancer

A beautiful tribute @Prof_IanD @ANZUPtrials for our much loved @MargaretMcJann1 #OzOnc

Ian Davis @Prof_IanD

2 months ago

A beautiful tribute @Prof_IanD @ANZUPtrials for our much loved @MargaretMcJann1 #OzOnc

keyboard_arrow_left Previous keyboard_arrow_right Next

0 6 23 2K 0

Download Image

Welcoming, with thanks, participant #55 in the #OXTOX #ClinicalTrial with team at Eastern Health in Vic helping us understand if #ibudilast prevents or reduces #CIPN in people #CRCSM on #oxaliplatin @GICancer @POCOG1 @Sydney_Science @syd_health #OzOnc

3 people in 1 day, #OxTOx #RCT has 53 participants. Thank you to 2 new people from Central Coast Cancer Centre & 1 from RNSH - & of course to #ClinicalTrial teams at both sites. #SuppOnc #OzOnc @GICancer @janette_vardy @COSAoncology @UTS_CST @POCOG1

& on 1st Feb, colleagues @ Central Coast Cancer Centre randomised participant 51 to #OxTox. Grateful to participant helping us learn about interventions for #CIPN #CRCSM @GICancer @janette_vardy @SuppOnc #OzOnc

2/2 Thanks also to everyone from the #OzOnc community who participated in #cancer #fearofrecurrence clinical pathway Delphi study. The final reminder for the 5 min Round 3 survey was emailed to participants on Tuesday & closes tomorrow! Last-minute input welcome! @COSAoncology

Great to share our mixed methods exploration of Survivorship Care Plan #SCP utility with #GP & #CancerSpecialists. well done @CindyTa09878114 @janette_vardy @AshMalalasekera #SurvOnc #SuppOnc #PsyOnc #OzOnc @COSA_Surviv @POCOG1 onlinelibrary.wiley.com/doi/full/10.11…

Great to share this work in people with #tscsm. Well done to @ciaraconduit @amandahut #SurvOnc #PsyOnc #OzOnc @ANZUPtrials @POCOG1 @COSA_Surviv @UsydPsych

Ciara Conduit @ciaraconduit

5 months ago

Great to share this work in people with #tscsm. Well done to @ciaraconduit @amandahut #SurvOnc #PsyOnc #OzOnc @ANZUPtrials @POCOG1 @COSA_Surviv @UsydPsych

1 3 11 1K 0

Always a joy to spend time with #OzOnc #PsyOnc & @POCOG1 community ⁦@COSAoncology⁩ meetings #cosa23 ⁦@laura__kirsten⁩ ⁦@nienkezomerdijk⁩ ⁦@usansomdaly⁩ ⁦@DrPeate⁩ ⁦@Lisa_Beatty⁩ ⁦@rebekah_lp⁩ ⁦@janette_vardy⁩ ⁦@WileyResearch⁩

The Australian Cancer Plan has lift off! 🚀 Launched at #COSA23 in recognition of the important role of @COSAoncology in developing & implementing the plan #OzOnc

Grateful to participant #41 & team @CeraCRGH for randomising to #OXTOX study this morning. 41/100 people taking part in study to prevent #CIPN in people with #CRCSM #bowelcancer receiving oxaliplatin #SuppOnc #OzOnc @janette_vardy @drprunellab @MartinStockler

Work done with @jefardell @CindyTa09878114 @janette_vardy & Kim Kerin-Ayres #OzOnc #ReturnToWork #FinTox #CRCI #Pain #EmotionalDistress

We developed recommendations for short or long-term implementation & consider low or high resource requirements for implementation. See Table below 👇 #SurvOnc #SuppOnc #OzOnc @COSA_Surviv @CancerAustralia @CancerCouncilOz @IPOSPsychoOncol

We asked cancer survivors attending Sydney Cancer Survivorship Centre Clinic if there is a need for change in cancer survivorship care? read about what we found here 👇 link.springer.com/article/10.100… #SurvOnc #SuppOnc #OzOnc @CindyTa09878114 @janette_vardy @COSA_Surviv

We are proud of the PoCoG team who were selected to present over 10 posters at @NSWCancerConf Check out our LinkedIn as we share some of the poster presentations! linkedin.com/feed/update/ur… #CancerResearch #OzOnc #PsyOnc